Role of IGF-Binding Protein 3 in the Resistance of EGFR Mutant Lung Cancer Cells to EGFR-Tyrosine Kinase InhibitorsYun Jung Choi(Asan Medical Center), Jae Cheol Lee(Ulsan College)PLoS ONEDecember 5, 201310.1371/journal.pone.0081393Cited by 11SaveCiteExport RISWatch citationsRelated PapersActivation of the IGF1R pathway potentially mediates acquired resistance to mutant-selective 3rd-generation EGF receptor tyrosine kinase inhibitors in advanced non-small cell lung cancer|Oncotarget|2016|70Autophagosome-Mediated EGFR Down-Regulation Induced by the CK2 Inhibitor Enhances the Efficacy of EGFR-TKI on EGFR-Mutant Lung Cancer Cells with Resistance by T790M|PLoS ONE|2014|28AUY922 Effectively Overcomes MET- and AXL-Mediated Resistance to EGFR-TKI in Lung Cancer Cells|PLoS ONE|2015|25The Reversible Fourth-Generation EGFR Tyrosine Kinase Inhibitor OBX02–011 Overcomes C797S-Mediated Resistance in Lung Cancer|Cancer Research|2022|5